Home > Boards > US Listed > Medical - Healthcare > Interpace Diagnostics Group Inc. (IDXG)

News: $IDXG Interpace Diagnostics Enters Agreement with Predictive

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 51
Posts 6,567
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 ... GlobeNewswire Inc. - 11/13/2019 4:40:22 PM
Interpace to Host Conference Call and Webcast to Discuss Third Quarter 2019 Financial Results on Wednesday, November 13, 2019... GlobeNewswire Inc. - 11/12/2019 6:55:00 AM
Interpace Diagnostics Announces Publication of New Data on Thyroid Test Utility GlobeNewswire Inc. - 11/4/2019 6:55:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 11/1/2019 4:41:45 PM
Interpace to Present Data at the ATA Annual Meeting GlobeNewswire Inc. - 10/29/2019 6:55:05 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/28/2019 4:20:05 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/28/2019 4:19:30 PM
Cancer Genetics, Inc. Announces Strategic Transactions GlobeNewswire Inc. - 10/24/2019 4:15:05 PM
Interpace to Present at the American College of Gastroenterology Conference GlobeNewswire Inc. - 10/24/2019 6:55:05 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 10/22/2019 6:01:17 AM
Post-effective Amendment to an S-8 Filing (s-8 Pos) Edgar (US Regulatory) - 10/22/2019 6:01:06 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/18/2019 4:23:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/18/2019 4:16:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/17/2019 4:20:45 PM
Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners GlobeNewswire Inc. - 10/17/2019 6:55:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2019 5:18:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2019 4:41:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2019 4:39:31 PM
Interpace Named to ‘Most Admired Companies’ List GlobeNewswire Inc. - 10/15/2019 6:55:00 AM
Interpace Announces New Contracts with Multiple Blue Cross Blue Shield Plans GlobeNewswire Inc. - 9/30/2019 6:55:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/20/2019 4:47:01 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/20/2019 4:43:49 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 9/20/2019 6:01:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/20/2019 6:01:05 AM
Interpace to Present at The Ladenburg Thalmann 2019 Healthcare Conference GlobeNewswire Inc. - 9/18/2019 6:55:00 AM
whytestocks Member Level  Thursday, 07/18/19 12:40:23 PM
Re: None
Post # of 2749 
News: $IDXG Interpace Diagnostics Enters Agreement with Predictive Oncology to Enhance Diagnosis of Thyroid Cancer Via AI-Driven Analysis

PARSIPPANY, NJ, July 18, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company), announced today that it has executed an agreement with the Helomics division of Predictive Oncology (NASDAQ: POAI), a company focused on app...

Got this from Interpace Diagnostics Enters Agreement with Predictive Oncology to Enhance Diagnosis of Thyroid Cancer Via AI-Driven Analysis

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist